SlideShare a Scribd company logo
2
Most read
3
Most read
8
Most read
QUALITY MANAGEMENT SYSTEM (MQA-102T)
UNIT IV
Quality Risk Management - ICH Q9 Guidelines
Presented By
V. Manikandan,
Roll No. 2061050002,
M. Pharm (Pharmaceutical Quality Assurance) – I Year,
Batch : 2020-2022,
Department of Pharmacy,
Annamalai University.
Submitted to
Dr. K. Devi, M. Pharm., Ph. D,
Assistant Professor,
Department of Pharmacy,
Annamalai University.
ICH Q9: Pharmaceutical Risk Management
1. Introduction
• The importance of quality systems has been recognized in the pharmaceutical industry and it is becoming
evident that quality risk management is a valuable component of an effective quality system.
• The purpose of this document is to offer a systematic approach to quality risk management.
• It specifically provides guidance on the principles and some of the tools of quality risk management that can
enable more effective and consistent risk-based decisions, both by regulators and industry, regarding the quality
of drug substances and drug (medicinal) products across the product lifecycle.
• An effective quality risk management approach can further ensure the high quality of the drug (medicinal)
product to the patient by providing a proactive means to identify and control potential quality issues during
development and manufacturing.
• Additionally, use of quality risk management can improve the decision making if a quality problem arises.
2. Risk Assessment
• Quality risk assessments begin with a well-defined problem description or risk question. When the risk in
question is well defined, an appropriate risk management tool and the types of information needed to address
the risk question will be more readily identifiable.
• As an aid to clearly defining the risk(s) for risk assessment purposes, three fundamental questions are often
helpful,
i. What might go wrong?
ii. What is the likelihood (probability) it will go wrong?
iii. What are the consequences (severity)?
• The output of a risk assessment is expressed in two methods,
i. Quantitative estimate of risk : expressed quantitatively, a numerical probability is used
ii. Qualitative description of risk: qualitative descriptors, such as “high”, “medium”, or “low”, which should
be defined in as much detail as possible
• Sometimes a "risk score" is used to further define descriptors in risk ranking.
3. Risk Control
• Risk control includes decision making to reduce and/or accept risks.
• The purpose of risk control is to reduce the risk to an acceptable level.
• The amount of effort used for risk control should be proportional to the significance of the risk.
• Decision makers might use different processes, including benefit-cost analysis, for understanding the optimal
level of risk control.
• Risk control might focus on the following questions:
i. Is the risk above an acceptable level?
ii. What can be done to reduce or eliminate risks?
iii. What is the appropriate balance among benefits, risks and resources?
iv. Are new risks introduced as a result of the identified risks being controlled?
• Risk reduction focuses on processes for mitigation or avoidance of quality risk when it exceeds a specified
(acceptable) level.
• Risk reduction might include actions taken to mitigate the severity and probability of harm.
• Processes that improve the detectability of hazards and quality risks might also be used as part of a risk control
strategy.
• The implementation of risk reduction measures can introduce new risks into the system or increase the
significance of other existing risks.
• Hence, it might be appropriate to revisit the risk assessment to identify and evaluate any possible change in risk
after implementing a risk reduction process.
• Risk acceptance is a decision to accept risk. Risk acceptance can be a formal decision to accept the residual risk
or it can be a passive decision in which residual risks are not specified.
• For some types of harms, even the best quality risk management practices might not entirely eliminate risk.
• In these circumstances, it might be agreed that an appropriate quality risk management strategy has been applied
and that quality risk is reduced to a specified (acceptable) level.
• This (specified) acceptable level will depend on many parameters and should be decided on a case-by-case basis.
4. Risk Review
• Risk management should be an ongoing part of the quality management process.
• A mechanism to review or monitor events should be implemented.
• Once a quality risk management process has been initiated, that process should continue to be utilized for events
that might impact the original quality risk management decision, whether these events are planned (e.g., results
of product review, inspections, audits, change control) or unplanned (e.g., root cause from failure investigations,
recall).
• The frequency of any review should be based upon the level of risk. Risk review might include reconsideration
of risk acceptance decisions (section 4.4).
5. Risk Assessment Tools
• Quality Risk management should be carried out based on the following principle
i. Evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the
protection of the patient.
ii. Level of effort, formality and documentation of the quality risk management process should be appropriate
with the level of risk.
• The following risk assessment tools should be used for risk management process
i. Failure Mode Effects Analysis (FMEA)
ii. Failure Mode, Effects and Criticality Analysis (FMECA)
iii. Fault Tree Analysis (FTA)
iv. Hazard Analysis and Critical Control Points (HACCP)
v. Hazard Operability Analysis (HAZOP)
vi. Preliminary Hazard Analysis (PHA)
vii. Risk ranking and filtering
viii. Supporting statistical tools
6. Hazard Analysis and Critical Control Point (HACCP)
• HACCP technique is a systematic, proactive, and preventive method for assuring product quality, reliability and
safety . This technique would typically be applied for the following potential area of use,
i. To identify and manage risks associated with physical, chemical and biological hazards (including
microbiological contamination)
ii. Useful when process understanding is sufficiently comprehensive to support identification of critical
control points (critical parameters variables)
iii. iii. Facilitates monitoring of critical points in the manufacturing process.
• HACCP should be performed as per the following procedure,
i. Conduct hazard analysis: identify preventive measures for each step of the process
ii. Determine critical control points (CCPs)
iii. Establish target levels and critical limit(s)
iv. Establish system to monitor the CCPs
v. Establish corrective actions to be taken, if CCP is out of control
vi. Establish verification procedures, that HACCP works effectively vii. Establish documentation of all
procedures and keep records
7. Risk Ranking and Filtering
• Risk ranking and filtering is a tool for comparing and ranking risks. Risk ranking of complex systems typically
requires evaluation of multiple diverse quantitative and qualitative factors for each risk.
• The tool involves breaking down a basic risk question into as many components as needed to capture factors
involved in the risk.
• These factors are combined into a single relative risk score that can then be used for ranking risks. “Filters,” in
the form of weighting factors or cut-offs for risk scores, can be used to scale or fit the risk ranking to
management or policy objectives.
• Potential Areas of Use(s)
• Risk ranking and filtering can be used to prioritize manufacturing sites for inspection/audit by regulators or
industry.
• Risk ranking methods are particularly helpful in situations in which the portfolio of risks and the underlying
consequences to be managed are diverse and difficult to compare using a single tool.
• Risk ranking is useful when management needs to evaluate both quantitatively-assessed and qualitatively-
assessed risks within the same organizational framework.
REFERENCES
 https://www.ich.org (ICH Quality Guidelines)
• Q9 – Pharmaceutical Risk Management
THANK YOU

More Related Content

PPTX
ICH AND ICH GUIDELINES
PPTX
Equipment qualification
PPTX
Cdsco ppt
PPT
Tablets
PPTX
ICH Guidelines
PPTX
Pharmaceutical industrial safety
PPTX
Quality risk management
PPTX
CHANGE CONTROL
ICH AND ICH GUIDELINES
Equipment qualification
Cdsco ppt
Tablets
ICH Guidelines
Pharmaceutical industrial safety
Quality risk management
CHANGE CONTROL

What's hot (20)

PPTX
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT
PPTX
Quality System and Audit.pptx
PPTX
Role of quality system and audits in pharmamaceutical
PPTX
Audit and Regulatory compliance
PPTX
Batch Review And Batch Release.pptx
PPTX
BACPAC
PPTX
Vendor qualification
PPTX
Auditing of capsule, sterile production and packaging
PPTX
Auditing of sterile poduction
PPTX
Auditing of vendors and production department
PPTX
Role of quality systems and audits in pharmaceutical manufacturing environment
PPTX
Ipqc and fpqc test for suppositories
PPTX
Auditing of quality assurance and maintenance of engineering department
DOCX
Pharmaceutical validation
PPTX
SUPAC, BACPAC, Post Marketing Surveillance
PPTX
Quality by Design and Process Analytical Technology
PPTX
Vendor Audites
PPTX
IPQC of Sterile Ointment.pptx
PPTX
Air circulation
PPTX
Pharmaceutical inspection convention
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT
Quality System and Audit.pptx
Role of quality system and audits in pharmamaceutical
Audit and Regulatory compliance
Batch Review And Batch Release.pptx
BACPAC
Vendor qualification
Auditing of capsule, sterile production and packaging
Auditing of sterile poduction
Auditing of vendors and production department
Role of quality systems and audits in pharmaceutical manufacturing environment
Ipqc and fpqc test for suppositories
Auditing of quality assurance and maintenance of engineering department
Pharmaceutical validation
SUPAC, BACPAC, Post Marketing Surveillance
Quality by Design and Process Analytical Technology
Vendor Audites
IPQC of Sterile Ointment.pptx
Air circulation
Pharmaceutical inspection convention
Ad

Similar to ICH Q9 Guidelines (20)

PPTX
ICH Q9.pptx
PPTX
Quality Risk Management
PPTX
Quality risk management
PPTX
Quality Risk Management.pptx
PDF
ICH Guideline Q9 - Quality Risk Management
PPTX
UNIT-IITechnology Transfer Protocol.pptx
PPTX
Quality management system(qrm)
PPTX
ICH Q9 presentation required for pharmaceuticals .pptx
PDF
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
PPTX
Quality Risk Management (ICHQ9). Understanding and Implimentation pptx
PPSX
Presentation on QRM_NS
PPTX
Quality Risk Management
PDF
ICH Q9 Quality Risk Management
PPTX
Quality risk management
PDF
Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"
PPTX
ICH Guideline – Q9
PPTX
Seminar on Quality Risk Management by Parag Ghadigaonkar
PPTX
Ich guidelines on risk assessment and risk mangment
PDF
Quality Risk Management
PPTX
Risk management in pharmaceutical Industry
ICH Q9.pptx
Quality Risk Management
Quality risk management
Quality Risk Management.pptx
ICH Guideline Q9 - Quality Risk Management
UNIT-IITechnology Transfer Protocol.pptx
Quality management system(qrm)
ICH Q9 presentation required for pharmaceuticals .pptx
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
Quality Risk Management (ICHQ9). Understanding and Implimentation pptx
Presentation on QRM_NS
Quality Risk Management
ICH Q9 Quality Risk Management
Quality risk management
Risk Based Thinking - RMSP "RISK MANAGEMENT SYSTEM PROCESS"
ICH Guideline – Q9
Seminar on Quality Risk Management by Parag Ghadigaonkar
Ich guidelines on risk assessment and risk mangment
Quality Risk Management
Risk management in pharmaceutical Industry
Ad

More from MANIKANDAN V (15)

PPTX
Literature Review and Bibliography
PPTX
Auditing for Sterile Production Area
PPTX
Hazards and Risk Management
PPTX
Fire and Explosion
PPTX
Chemical Hazards
PPTX
Fire Prevention and Protection
PPTX
Preliminary Hazard Analysis
PPTX
Natural Resources
PPTX
Principles of Drug Discovery and Development
PPTX
IND, NDA, ANDA, SNDA
PPTX
IPQC Test for Liquid Dosage Forms
PPTX
cGMP Guidelines according to USFDA
PPTX
Overview of ICH Guidelines, CPCSEA
PPTX
ICH Stability Guidelines
PPTX
ICH Q8 Guidelines
Literature Review and Bibliography
Auditing for Sterile Production Area
Hazards and Risk Management
Fire and Explosion
Chemical Hazards
Fire Prevention and Protection
Preliminary Hazard Analysis
Natural Resources
Principles of Drug Discovery and Development
IND, NDA, ANDA, SNDA
IPQC Test for Liquid Dosage Forms
cGMP Guidelines according to USFDA
Overview of ICH Guidelines, CPCSEA
ICH Stability Guidelines
ICH Q8 Guidelines

Recently uploaded (20)

PDF
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
PDF
The Final Stretch: How to Release a Game and Not Die in the Process.
PPTX
BOWEL ELIMINATION FACTORS AFFECTING AND TYPES
PPTX
human mycosis Human fungal infections are called human mycosis..pptx
PPTX
master seminar digital applications in india
PPTX
Open Quiz Monsoon Mind Game Final Set.pptx
PDF
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
PPTX
PPH.pptx obstetrics and gynecology in nursing
PPTX
PPT- ENG7_QUARTER1_LESSON1_WEEK1. IMAGERY -DESCRIPTIONS pptx.pptx
PDF
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
PPTX
Week 4 Term 3 Study Techniques revisited.pptx
PDF
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
PPTX
COMPUTERS AS DATA ANALYSIS IN PRECLINICAL DEVELOPMENT.pptx
PDF
Pre independence Education in Inndia.pdf
PDF
Saundersa Comprehensive Review for the NCLEX-RN Examination.pdf
PPTX
Cell Structure & Organelles in detailed.
PDF
Abdominal Access Techniques with Prof. Dr. R K Mishra
PPTX
Introduction to Child Health Nursing – Unit I | Child Health Nursing I | B.Sc...
PDF
STATICS OF THE RIGID BODIES Hibbelers.pdf
PDF
BÀI TẬP BỔ TRỢ 4 KỸ NĂNG TIẾNG ANH 9 GLOBAL SUCCESS - CẢ NĂM - BÁM SÁT FORM Đ...
grade 11-chemistry_fetena_net_5883.pdf teacher guide for all student
The Final Stretch: How to Release a Game and Not Die in the Process.
BOWEL ELIMINATION FACTORS AFFECTING AND TYPES
human mycosis Human fungal infections are called human mycosis..pptx
master seminar digital applications in india
Open Quiz Monsoon Mind Game Final Set.pptx
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
PPH.pptx obstetrics and gynecology in nursing
PPT- ENG7_QUARTER1_LESSON1_WEEK1. IMAGERY -DESCRIPTIONS pptx.pptx
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
Week 4 Term 3 Study Techniques revisited.pptx
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
COMPUTERS AS DATA ANALYSIS IN PRECLINICAL DEVELOPMENT.pptx
Pre independence Education in Inndia.pdf
Saundersa Comprehensive Review for the NCLEX-RN Examination.pdf
Cell Structure & Organelles in detailed.
Abdominal Access Techniques with Prof. Dr. R K Mishra
Introduction to Child Health Nursing – Unit I | Child Health Nursing I | B.Sc...
STATICS OF THE RIGID BODIES Hibbelers.pdf
BÀI TẬP BỔ TRỢ 4 KỸ NĂNG TIẾNG ANH 9 GLOBAL SUCCESS - CẢ NĂM - BÁM SÁT FORM Đ...

ICH Q9 Guidelines

  • 1. QUALITY MANAGEMENT SYSTEM (MQA-102T) UNIT IV Quality Risk Management - ICH Q9 Guidelines Presented By V. Manikandan, Roll No. 2061050002, M. Pharm (Pharmaceutical Quality Assurance) – I Year, Batch : 2020-2022, Department of Pharmacy, Annamalai University. Submitted to Dr. K. Devi, M. Pharm., Ph. D, Assistant Professor, Department of Pharmacy, Annamalai University.
  • 2. ICH Q9: Pharmaceutical Risk Management 1. Introduction • The importance of quality systems has been recognized in the pharmaceutical industry and it is becoming evident that quality risk management is a valuable component of an effective quality system. • The purpose of this document is to offer a systematic approach to quality risk management. • It specifically provides guidance on the principles and some of the tools of quality risk management that can enable more effective and consistent risk-based decisions, both by regulators and industry, regarding the quality of drug substances and drug (medicinal) products across the product lifecycle. • An effective quality risk management approach can further ensure the high quality of the drug (medicinal) product to the patient by providing a proactive means to identify and control potential quality issues during development and manufacturing. • Additionally, use of quality risk management can improve the decision making if a quality problem arises.
  • 3. 2. Risk Assessment • Quality risk assessments begin with a well-defined problem description or risk question. When the risk in question is well defined, an appropriate risk management tool and the types of information needed to address the risk question will be more readily identifiable. • As an aid to clearly defining the risk(s) for risk assessment purposes, three fundamental questions are often helpful, i. What might go wrong? ii. What is the likelihood (probability) it will go wrong? iii. What are the consequences (severity)? • The output of a risk assessment is expressed in two methods, i. Quantitative estimate of risk : expressed quantitatively, a numerical probability is used ii. Qualitative description of risk: qualitative descriptors, such as “high”, “medium”, or “low”, which should be defined in as much detail as possible • Sometimes a "risk score" is used to further define descriptors in risk ranking.
  • 4. 3. Risk Control • Risk control includes decision making to reduce and/or accept risks. • The purpose of risk control is to reduce the risk to an acceptable level. • The amount of effort used for risk control should be proportional to the significance of the risk. • Decision makers might use different processes, including benefit-cost analysis, for understanding the optimal level of risk control. • Risk control might focus on the following questions: i. Is the risk above an acceptable level? ii. What can be done to reduce or eliminate risks? iii. What is the appropriate balance among benefits, risks and resources? iv. Are new risks introduced as a result of the identified risks being controlled? • Risk reduction focuses on processes for mitigation or avoidance of quality risk when it exceeds a specified (acceptable) level. • Risk reduction might include actions taken to mitigate the severity and probability of harm.
  • 5. • Processes that improve the detectability of hazards and quality risks might also be used as part of a risk control strategy. • The implementation of risk reduction measures can introduce new risks into the system or increase the significance of other existing risks. • Hence, it might be appropriate to revisit the risk assessment to identify and evaluate any possible change in risk after implementing a risk reduction process. • Risk acceptance is a decision to accept risk. Risk acceptance can be a formal decision to accept the residual risk or it can be a passive decision in which residual risks are not specified. • For some types of harms, even the best quality risk management practices might not entirely eliminate risk. • In these circumstances, it might be agreed that an appropriate quality risk management strategy has been applied and that quality risk is reduced to a specified (acceptable) level. • This (specified) acceptable level will depend on many parameters and should be decided on a case-by-case basis.
  • 6. 4. Risk Review • Risk management should be an ongoing part of the quality management process. • A mechanism to review or monitor events should be implemented. • Once a quality risk management process has been initiated, that process should continue to be utilized for events that might impact the original quality risk management decision, whether these events are planned (e.g., results of product review, inspections, audits, change control) or unplanned (e.g., root cause from failure investigations, recall). • The frequency of any review should be based upon the level of risk. Risk review might include reconsideration of risk acceptance decisions (section 4.4). 5. Risk Assessment Tools • Quality Risk management should be carried out based on the following principle i. Evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the protection of the patient. ii. Level of effort, formality and documentation of the quality risk management process should be appropriate with the level of risk.
  • 7. • The following risk assessment tools should be used for risk management process i. Failure Mode Effects Analysis (FMEA) ii. Failure Mode, Effects and Criticality Analysis (FMECA) iii. Fault Tree Analysis (FTA) iv. Hazard Analysis and Critical Control Points (HACCP) v. Hazard Operability Analysis (HAZOP) vi. Preliminary Hazard Analysis (PHA) vii. Risk ranking and filtering viii. Supporting statistical tools 6. Hazard Analysis and Critical Control Point (HACCP) • HACCP technique is a systematic, proactive, and preventive method for assuring product quality, reliability and safety . This technique would typically be applied for the following potential area of use, i. To identify and manage risks associated with physical, chemical and biological hazards (including microbiological contamination)
  • 8. ii. Useful when process understanding is sufficiently comprehensive to support identification of critical control points (critical parameters variables) iii. iii. Facilitates monitoring of critical points in the manufacturing process. • HACCP should be performed as per the following procedure, i. Conduct hazard analysis: identify preventive measures for each step of the process ii. Determine critical control points (CCPs) iii. Establish target levels and critical limit(s) iv. Establish system to monitor the CCPs v. Establish corrective actions to be taken, if CCP is out of control vi. Establish verification procedures, that HACCP works effectively vii. Establish documentation of all procedures and keep records 7. Risk Ranking and Filtering • Risk ranking and filtering is a tool for comparing and ranking risks. Risk ranking of complex systems typically requires evaluation of multiple diverse quantitative and qualitative factors for each risk.
  • 9. • The tool involves breaking down a basic risk question into as many components as needed to capture factors involved in the risk. • These factors are combined into a single relative risk score that can then be used for ranking risks. “Filters,” in the form of weighting factors or cut-offs for risk scores, can be used to scale or fit the risk ranking to management or policy objectives. • Potential Areas of Use(s) • Risk ranking and filtering can be used to prioritize manufacturing sites for inspection/audit by regulators or industry. • Risk ranking methods are particularly helpful in situations in which the portfolio of risks and the underlying consequences to be managed are diverse and difficult to compare using a single tool. • Risk ranking is useful when management needs to evaluate both quantitatively-assessed and qualitatively- assessed risks within the same organizational framework.
  • 10. REFERENCES  https://www.ich.org (ICH Quality Guidelines) • Q9 – Pharmaceutical Risk Management